ArticleFrontiers in oncology2025

Ibrutinib combined with rituximab and high-dose methotrexate in newly diagnosed primary CNS diffuse large B-cell lymphoma: a pilot study with long-term follow-up.

Yixian Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.